Hypolipidemic effect of peroxisome proliferators. Transcriptional suppression of apolipoprotein C-III.
Hertz
R
R
Department of Human Nutrition and Metabolism, Hebrew University, Faculty of Medicine, Jerusalem, Israel.
Bishara-Shieban
J
J
Bar-Tana
J
J
D000818:Animals; D053305:Apolipoprotein C-III; D001056:Apolipoproteins C / Q000235:genetics*; D001629:Bezafibrate / Q000494:pharmacology; D002467:Cell Nucleus / Q000378:metabolism; D004268:DNA-Binding Proteins; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D051557:Hepatocyte Nuclear Factor 4; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D008830:Microbodies / Q000187:drug effects*; D010169:Palmitic Acids / Q000494:pharmacology; D010750:Phosphoproteins / Q000502:physiology; D051381:Rats; D014157:Transcription Factors / Q000502:physiology; D014158:Transcription, Genetic / Q000187:drug effects
D053305:Apolipoprotein C-III; D001056:Apolipoproteins C; D004268:DNA-Binding Proteins; D051557:Hepatocyte Nuclear Factor 4; D000960:Hypolipidemic Agents; D010169:Palmitic Acids; D010750:Phosphoproteins; D014157:Transcription Factors; C056166:MEDICA 16; D001629:Bezafibrate